SCS Capital Management’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.77M Hold
197,998
0.03% 194
2025
Q1
$2.69M Buy
+197,998
New +$2.69M 0.03% 172